300 related articles for article (PubMed ID: 31407970)
1. White Matter by Diffusion MRI Following Methylphenidate Treatment: A Randomized Control Trial in Males with Attention-Deficit/Hyperactivity Disorder.
Bouziane C; Filatova OG; Schrantee A; Caan MWA; Vos FM; Reneman L
Radiology; 2019 Oct; 293(1):186-192. PubMed ID: 31407970
[TBL] [Abstract][Full Text] [Related]
2. Methylphenidate Effects on Cortical Thickness in Children and Adults with Attention-Deficit/Hyperactivity Disorder: A Randomized Clinical Trial.
Walhovd KB; Amlien I; Schrantee A; Rohani DA; Groote I; Bjørnerud A; Fjell AM; Reneman L
AJNR Am J Neuroradiol; 2020 May; 41(5):758-765. PubMed ID: 32414901
[TBL] [Abstract][Full Text] [Related]
3. Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder.
Newcorn JH; Nagy P; Childress AC; Frick G; Yan B; Pliszka S
CNS Drugs; 2017 Nov; 31(11):999-1014. PubMed ID: 28980198
[TBL] [Abstract][Full Text] [Related]
4. Do effects of methylphenidate on cognitive performance last beyond treatment? A randomized placebo-controlled trial in boys and men with ADHD.
Tamminga HGH; Reneman L; Schrantee A; Bottelier MA; Bouziane C; Geurts HM; Groenman AP
Eur Neuropsychopharmacol; 2021 May; 46():1-13. PubMed ID: 33735707
[TBL] [Abstract][Full Text] [Related]
5. Age-Dependent Effects of Methylphenidate on the Human Dopaminergic System in Young vs Adult Patients With Attention-Deficit/Hyperactivity Disorder: A Randomized Clinical Trial.
Schrantee A; Tamminga HG; Bouziane C; Bottelier MA; Bron EE; Mutsaerts HJ; Zwinderman AH; Groote IR; Rombouts SA; Lindauer RJ; Klein S; Niessen WJ; Opmeer BC; Boer F; Lucassen PJ; Andersen SL; Geurts HM; Reneman L
JAMA Psychiatry; 2016 Sep; 73(9):955-62. PubMed ID: 27487479
[TBL] [Abstract][Full Text] [Related]
6. Stimulant treatment history predicts frontal-striatal structural connectivity in adolescents with attention-deficit/hyperactivity disorder.
Schweren LJ; Hartman CA; Zwiers MP; Heslenfeld DJ; Franke B; Oosterlaan J; Buitelaar JK; Hoekstra PJ
Eur Neuropsychopharmacol; 2016 Apr; 26(4):674-83. PubMed ID: 26899587
[TBL] [Abstract][Full Text] [Related]
7. Methylphenidate normalizes frontocingulate underactivation during error processing in attention-deficit/hyperactivity disorder.
Rubia K; Halari R; Mohammad AM; Taylor E; Brammer M
Biol Psychiatry; 2011 Aug; 70(3):255-62. PubMed ID: 21664605
[TBL] [Abstract][Full Text] [Related]
8. Attention deficit/hyperactivity disorder and medication with stimulants in young children: a DTI study.
de Luis-García R; Cabús-Piñol G; Imaz-Roncero C; Argibay-Quiñones D; Barrio-Arranz G; Aja-Fernández S; Alberola-López C
Prog Neuropsychopharmacol Biol Psychiatry; 2015 Mar; 57():176-84. PubMed ID: 25445066
[TBL] [Abstract][Full Text] [Related]
9. A randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of osmotic-controlled release oral delivery system methylphenidate HCl in adults with attention-deficit/hyperactivity disorder in Japan.
Takahashi N; Koh T; Tominaga Y; Saito Y; Kashimoto Y; Matsumura T
World J Biol Psychiatry; 2014 Aug; 15(6):488-98. PubMed ID: 24456065
[TBL] [Abstract][Full Text] [Related]
10. Randomized, controlled trial of oros methylphenidate once a day in children with attention-deficit/hyperactivity disorder.
Wolraich ML; Greenhill LL; Pelham W; Swanson J; Wilens T; Palumbo D; Atkins M; McBurnett K; Bukstein O; August G
Pediatrics; 2001 Oct; 108(4):883-92. PubMed ID: 11581440
[TBL] [Abstract][Full Text] [Related]
11. Effects of Methylphenidate on Sleep Functioning in Children with Attention-Deficit/Hyperactivity Disorder.
Becker SP; Froehlich TE; Epstein JN
J Dev Behav Pediatr; 2016 Jun; 37(5):395-404. PubMed ID: 27011002
[TBL] [Abstract][Full Text] [Related]
12. Drug-specific laterality effects on frontal lobe activation of atomoxetine and methylphenidate in attention deficit hyperactivity disorder boys during working memory.
Cubillo A; Smith AB; Barrett N; Giampietro V; Brammer M; Simmons A; Rubia K
Psychol Med; 2014 Feb; 44(3):633-46. PubMed ID: 23597077
[TBL] [Abstract][Full Text] [Related]
13. COMT genotype affects brain white matter pathways in attention-deficit/hyperactivity disorder.
Hong SB; Zalesky A; Park S; Yang YH; Park MH; Kim B; Song IC; Sohn CH; Shin MS; Kim BN; Cho SC; Kim JW
Hum Brain Mapp; 2015 Jan; 36(1):367-77. PubMed ID: 25201318
[TBL] [Abstract][Full Text] [Related]
14. OROS-methylphenidate efficacy on specific executive functioning deficits in adults with ADHD: a randomized, placebo-controlled cross-over study.
Bron TI; Bijlenga D; Boonstra AM; Breuk M; Pardoen WF; Beekman AT; Kooij JJ
Eur Neuropsychopharmacol; 2014 Apr; 24(4):519-28. PubMed ID: 24508533
[TBL] [Abstract][Full Text] [Related]
15. The age-dependent effects of a single-dose methylphenidate challenge on cerebral perfusion in patients with attention-deficit/hyperactivity disorder.
Schrantee A; Mutsaerts H; Bouziane C; Tamminga H; Bottelier MA; Reneman L
Neuroimage Clin; 2017; 13():123-129. PubMed ID: 27942455
[TBL] [Abstract][Full Text] [Related]
16. First-Dose Methylphenidate-Induced Changes in Brain Functional Connectivity Are Correlated With 3-Month Attention-Deficit/Hyperactivity Disorder Symptom Response.
Silberstein RB; Levy F; Pipingas A; Farrow M
Biol Psychiatry; 2017 Nov; 82(9):679-686. PubMed ID: 28465019
[TBL] [Abstract][Full Text] [Related]
17. The effects of Psychotropic drugs On Developing brain (ePOD) study: methods and design.
Bottelier MA; Schouw ML; Klomp A; Tamminga HG; Schrantee AG; Bouziane C; de Ruiter MB; Boer F; Ruhé HG; Denys D; Rijsman R; Lindauer RJ; Reitsma HB; Geurts HM; Reneman L
BMC Psychiatry; 2014 Feb; 14():48. PubMed ID: 24552282
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of Methylphenidate Hydrochloride Extended-Release Capsules (Aptensio XR™) in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Phase III, Randomized, Double-Blind Study.
Wigal SB; Nordbrock E; Adjei AL; Childress A; Kupper RJ; Greenhill L
CNS Drugs; 2015 Apr; 29(4):331-40. PubMed ID: 25877989
[TBL] [Abstract][Full Text] [Related]
19. Age-dependent effects of acute methylphenidate on amygdala reactivity in stimulant treatment-naive patients with Attention Deficit/Hyperactivity Disorder.
Bottelier MA; Schrantee A; Ferguson B; Tamminga HGH; Bouziane C; Kooij JJS; de Ruiter MB; Reneman L
Psychiatry Res Neuroimaging; 2017 Nov; 269():36-42. PubMed ID: 28938219
[TBL] [Abstract][Full Text] [Related]
20. Empathy and Facial Expression Recognition in Children With and Without Attention-Deficit/Hyperactivity Disorder: Effects of Stimulant Medication on Empathic Skills in Children with Attention-Deficit/Hyperactivity Disorder.
Gumustas F; Yilmaz I; Yulaf Y; Gokce S; Sabuncuoglu O
J Child Adolesc Psychopharmacol; 2017 Jun; 27(5):433-439. PubMed ID: 28332851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
